wydrukuj poleć znajomym zamów materiały
Od ilu lat pracuje Pani/Pan na różnych stanowiskach menedżerskich:

powyżej 20 lat
powyżej 15 lat
powyżej 10 lat
powyżej 5 lat
poniżej 5 lat
jeszcze nie byłam/-em menedżerem
nie chcę być menedżerem


Subskrypcja najnowszych ofert pracy





Nasi partnerzy:

rp.pl
gazeta.pl
onet.pl
interia.pl
wp.pl

IBM Watson Ushers in a New Era of Data-Driven Discoveries 2014.08.30

New York, N.Y., USA - August 28, 2014 - IBM (NYSE: IBM) today announced significant advances in Watson's cognitive computing capabilities that are enabling researchers to accelerate the pace of scientific breakthroughs by discovering previously unknown connections in Big Data. Available now as a cloud service, IBM's Watson Discovery Advisor is designed to scale and accelerate discoveries by research teams. It reduces the time needed to test hypotheses and formulate conclusions that can advance their work - from months to days and days to just hours - bringing new levels of speed and precision to research and development. Building on Watson's ability to understand nuances in natural language, Watson Discovery Advisor can understand the language of science, such as how chemical compounds interact, making it a uniquely powerful tool for researchers in life sciences and other industries.

Scott Spangler, Principal Data Scientist, IBM Watson Innovations, demonstrates how IBM Watson cognitive technology can now visually display connections in scientific literature and drug information.
In this image, Watson displays protein pathways that can help researchers accelerate scientific breakthroughs by spotting linkages that were previously undetected.
Courtesy of IBM / Jon Simon / Feature Photo Service for IBM
 

New York, N.Y., USA - August 28, 2014

• Next Milestone in Cognitive Computing is Accelerating Scientific and Industrial Research

• Baylor College of Medicine Speeds Understanding of the Biology of Diseases

• Johnson & Johnson, Sanofi and New York Genome Center Launch Life Science Research Projects


IBM (NYSE: IBM) today announced significant advances in Watson's cognitive computing capabilities that are enabling researchers to accelerate the pace of scientific breakthroughs by discovering previously unknown connections in Big Data.

Available now as a cloud service, IBM's Watson Discovery Advisor is designed to scale and accelerate discoveries by research teams.

Scott Spangler, a data scientist with IBM, demonstrates how IBM's Watson cognitive technology can visually display connections in scientific data.
Courtesy of IBM / Jon Simon / Feature Photo Service for IBM
 
It reduces the time needed to test hypotheses and formulate conclusions that can advance their work - from months to days and days to just hours - bringing new levels of speed and precision to research and development.

Building on Watson's ability to understand nuances in natural language, Watson Discovery Advisor can understand the language of science, such as how chemical compounds interact, making it a uniquely powerful tool for researchers in life sciences and other industries.

Infographic: IBM Watson Transforms R&D Discoveries with Data.
Courtesy of IBM
 
Researchers and scientists from leading academic, pharmaceutical and other commercial research centers have begun deploying IBM's new Watson Discovery Advisor to rapidly analyze and test hypotheses using data in millions of scientific papers available in public databases
.

Courtesy of IBM
 
A new scientific research paper is published nearly every 30 seconds, which equals more than a million annually
(Source: CiteSeerx).

According to the National Institutes of Health, a typical researcher reads about 23 scientific papers per month, which translates to nearly 300 per year, making it humanly impossible to keep up with the ever-growing body of scientific material available.

Courtesy of IBM
 
In 2013, the top 1,000 research and development companies spent more than $600 billion annually on research alone (Source: Strategy&).

Progress can be slow, taking an average of 10 to 15 years for a promising pharmaceutical treatment to progress from the initial research stage into practice (Source: Pharmaceutical Research and Manufacturers of America).

Courtesy of IBM
 
Using Watson Discovery Advisor, researchers can uncover new relationships and recognize unexpected patterns among data that have the potential to significantly improve and accelerate the discovery process in research and science
.

Courtesy of IBM
 
“We're entering an extraordinary age of data-driven discovery,"
said Mike Rhodin, senior vice president, IBM Watson Group.
"Today's announcement is a natural extension of Watson's cognitive computing capability. We're empowering researchers with a powerful tool which will help increase the impact of investments organizations make in R&D, leading to significant breakthroughs."

Courtesy of IBM
 
Leading life sciences organizations are deploying Watson Discovery Advisor to advance discoveries in ongoing research projects, including Baylor College of Medicine, Johnson & Johnson and The New York Genome Center
.

Courtesy of IBM
 
In a retrospective, peer reviewed study released this week by Baylor College of Medicine and IBM, scientists demonstrated a possible new path for generating scientific questions that may be helpful in the long term development of new, effective treatments for disease.

In a matter of weeks, biologists and data scientists using the Baylor Knowledge Integration Toolkit (KnIT), based on Watson technology, accurately identified proteins that modify p53, an important protein related to many cancers, which can eventually lead to better efficacy of drugs and other treatments.

A feat that would have taken researchers years to accomplish without Watson's cognitive capabilities, Watson analyzed 70,000 scientific articles on p53 to predict proteins that turn on or off p53's activity.

This automated analysis led the Baylor cancer researchers to identify six potential proteins to target for new research.

These results are notable, considering that over the last 30 years, scientists averaged one similar target protein discovery per year.

Courtesy of IBM
 
“On average, a scientist might read between one and five research papers on a good day,”
said Dr. Olivier Lichtarge, the principal investigator and professor of molecular and human genetics, biochemistry and molecular biology at Baylor College of Medicine.
“To put this in perspective with p53, there are over 70,000 papers published on this protein. Even if I’m reading five papers a day, it could take me nearly 38 years to completely understand all of the research already available today on this protein. Watson has demonstrated the potential to accelerate the rate and the quality of breakthrough discoveries."

Courtesy of IBM
 
Johnson & Johnson
is collaborating with the IBM Watson Discovery Advisor team to teach Watson to read and understand scientific papers that detail clinical trial outcomes used to develop and evaluate medications and other treatments.

This collaboration hopes to accelerate comparative effectiveness studies of drugs, which help doctors match a drug with the right set of patients to maximize effectiveness and minimize side effects.

Typically, comparative effectiveness studies are done manually, requiring three people to spend an average of 10 months (2.5 man-years) just to collect the data and prepare them for use before they are able to start analyzing, generating and validating a hypothesis.

In this research study, the team hopes to teach Watson to quickly synthesize the information directly from the medical literature, allowing researchers to start asking questions about the data immediately to determine the effectiveness of a treatment compared to other medications, as well as its side effects.

Courtesy of IBM
 
Sanofi
is exploring how working with Watson can speed up the discovery of alternate indications for existing drugs (drug re-purposing).

Watson is able to understand and extract key information by reading millions of pages of scientific literature and then visualizes relationships between drugs and other potential diseases they could target while providing supporting evidence each step of the way.

Drug Safety and Toxicity is a major driver of the high failure rate in clinical development / trials.

Sanofi is exploring how Watson's ability to understand, extract and organize toxicological information can enable researchers to make better informed decisions with respect to candidate progression.

IBM Watson will be supporting the analysis in New York Genome Center’s clinical study to advance genomic medicine.

Courtesy of IBM
 
The clinical study will initially focus on clinical application of genomics to help oncologists deliver DNA-based treatment for glioblastoma, an aggressive form of brain cancer that kills more than 13,000 Americans each year.

Despite tremendous discoveries into the genetic drivers of diseases like cancer over the past decade, big data makes it difficult to translate DNA data into life-saving treatments.

Based on results from the clinical study, IBM Watson could soon help scale up the availability of personalized treatment options.


Industry Implications

Discovering something new is applicable to many domains such as medicine, law, finance, etc., that all require deep insight into a large body of information and protocols.

Cognitive computing will allow human experts to interact with large bodies of data and research and the knowledge and insight of many other experts in their field.

Courtesy of IBM
 
For example, Watson could be used to:


• Accelerate a medical researcher's ability to develop life-saving treatments for diseases by synthesizing evidence and removing reliance on serendipity

• Enhance a financial analyst's ability to provide proactive advice to clients

• Improve a lawyer's merger and acquisition strategy with faster, more comprehensive due diligence and document analysis

• Accelerate a government analyst's insight into security, intelligence, border protection and law enforcement and guidance, etc.

• Create new food recipes. Chefs can use Watson to augment their creativity and expertise and help them discover recipes, learning about the language of cooking and food by reading recipes, statistical, molecular and food pairing theories, hedonic chemistry, as well as regional and cultural knowledge

Courtesy of IBM
 
IBM Watson Discovery Advisor
has the potential to transform industries and professions that rely heavily on data, including law, pharmaceuticals, biotech, education, chemicals, metals, scientific research, engineering, and criminal investigations.

For more information, visit https://ibm.biz/watsondiscoveryadvisor 

IBM Power Systems serves as the infrastructure base of Watson, supporting the high volume of data needed to drive cognitive insights.

Photos are available via the Associated Press Photo Network and on the Internet at Feature Photo Service's link through http://www.newscom.com  


IBM Watson: Pioneering a New Era of Computing

Three years after its victory on the TV quiz show Jeopardy!, IBM Watson has evolved to represent a new era of computing, earning recognition from Frost & Sullivan, which presented IBM Watson with the 2013 North America Award for New Product Innovation, and Gartner Inc., which cites IBM Watson in its Top 10 Strategic Technology Trends for 2014 and predicts that by 2017, 10 percent of computers will be able to learn as Watson does.

Courtesy of IBM
 
Today, Watson is no longer just the world's most famous game-playing computer.

IBM has put Watson to work in various industries.

In healthcare, IBM is co-developing an application with Memorial Sloan-Kettering Cancer Center, and partnering with WellPoint, the University of Texas MD Anderson Cancer Center, and the Cleveland Clinic Lerner College of Medicine.

Courtesy of IBM
 
Additionally, IBM has partnered with numerous colleges and universities across the country to teach Watson capabilities and cognitive computing technology to the next generation workforce.

For more information on IBM Watson, please visit: www.ibmwatson.com  

To join the social discussion about Watson, include the hashtag #ibmwatson.

Follow Watson on Facebook and see Watson on YouTube and Flickr.

For more insights on this story please read these posts on IBM's A Smarter Planet blog: ibm.co/1tFVdly, ibm.co/XPzxIY, ibm.co/1vj8dQZ


Courtesy of IBM
 

Contacts information

John Connolly
IBM Media Relations

781-636-8512
jconnol@us.ibm.com  

Tod Freeman
IBM Media Relations

415.320.5893
tefreema@us.ibm.com  


Courtesy of IBM
 

Video
Introducing IBM Watson Discovery Advisor


http://www.youtube.com/watch?v=qry_zGZFjOc  


Source: IBM

http://www-03.ibm.com/press/us/en/index.wss  


Courtesy of IBM
 

ASTROMAN Magazine - 2014.08.10

Wroclaw University of Technology Delivers Personalized Classrooms on IBM Cloud Infrastructure

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1772  


ASTROMAN Magazine - 2014.08.02

IBM acquires CrossIdeas to Expand Security Offerings with Identity Intelligence

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1767  


ASTROMAN Magazine - 2014.07.16

Apple and IBM Forge Global Partnership to Transform Enterprise Mobility

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1757  


ASTROMAN Magazine - 2014.07.12

IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1755  


ASTROMAN Magazine - 2014.07.08

City of Madrid Implements IBM's Large Smarter Cities Environmental Analytics Project

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1751  


ASTROMAN Magazine - 2014.06.27

Qatar Public Works Authority 'Ashghal' Selects IBM for Smarter Infrastructure

https://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1741  


ASTROMAN Magazine - 2014.05.11

Report: IBM Named #1 Preferred Provider of IaaS Cloud by Enterprises

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1710  


ASTROMAN Magazine – 2014.02.01

IBM and Twitter Announce Patent and Cross-License Agreement. Twitter purchases 900 patents from IBM

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1648  


ASTROMAN Magazine - 2013.12.22

IBM to Acquire Aspera to Help Companies Speed Global Movement of Big Data

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1610  


ASTROMAN Magazine - 2013.11.16

IBM Watson's Next Venture: Fueling New Era of Cognitive Apps Built in the Cloud by Developers

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1587  


ASTROMAN Magazine - 2013.10.26

President Barack Obama to Visit IBM'S P-TECH School in Brooklyn, NY, USA

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1576  


ASTROMAN Magazine - 2013.09.21

IBM Acquires Daeja Image Systems Ltd.

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1557  


ASTROMAN Magazine - 2013.09.01

IBM Closes Acquisition of CSL International

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1541  


ASTROMAN Magazine – 2013.08.17

IBM to Acquire Trusteer to Help Companies Combat Financial Fraud and Advanced Security Threats

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1519  


ASTROMAN Magazine – 2013.08.17

IBM Awarded 10 Year US$1 Billion Cloud Hosting Services Contract

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1518  


ASTROMAN Magazine – 2013.04.08

IBM To Open Cloud Lab For Wall Street Clients

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1440  


 
 

ASTROMAN Magazine – 2012.03.03

IBM Forms Watson Healthcare Advisory Board

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1191  


ASTROMAN Magazine – 2011.11.01

IBM Watson Heads to Harvard, MIT to Explore Future of Technology in Business

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1092  


ASTROMAN Magazine – 2011.09.12

WellPoint and IBM Announce Agreement to Put Watson to Work in Health Care

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1056  


ASTROMAN Magazine – 2011.06.17

IBM's Watson Computing System Honored as "Person of the Year"

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=998  


ASTROMAN Magazine – 2011.02.20

IBM to Collaborate with Nuance to Apply IBM's "Watson" Analytics Technology to Healthcare

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=899  


ASTROMAN Magazine – 2011.02.20

IBM "Watson" to Challenge Humans at Jeopardy!

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=898  


ASTROMAN Magazine – 2010.12.25

IBM's "Watson" Computing System to Challenge All Time Greatest Jeopardy! Champions

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=864  



Editor-in-Chief of ASTROMAN magazine: Roman Wojtala, PhD.


wydrukuj ten artykuł
  strona: 1 z 1
polecamy artykuły
Airbus: Indigo Partners doubles existing A320neo Family order with commitment for additional 430 aircraft valued at USD49.5 billion
Fusion Genomics Turns to IBM Cloud to Help Support Advances Designed to Conquer Global Pandemics
Boeing, flydubai Sign Historic Deal for 225 737 MAX Airplanes Valued at USD27 billion
Cray Advanced Supercomputer to Assist Samsung's Research on Artificial Intelligence and Deep Learning
Rada Ministrów przyjęła Konstytucję Biznesu
Polski Fundusz Rozwoju nowym inwestorem w Grupie WB Electronics
Intelligent World Drive - five continents in five months. On the road to autonomous driving: Mercedes-Benz on automated worldwide test drive
BMW Connected further expands its digital ecosystem. BMW is now integrated with the Google Assistant
EICMA 2017: How Bosch is taking the motorcycle into the future. Bosch's two-wheeler and powersports business is growing twice as fast as the market
Raytheon Immersive Design Center wins Aviation Week 2017 Program Excellence award
Lockheed Martin Receives Contract to Develop Compact Airborne High Energy Laser Capabilities
Fujitsu, Lenovo and Development Bank of Japan form PC Joint Venture
Newest Cisco tech for the future of work will keep you occupied. Daylight Saving Time: Putting one extra hour to good use
Boeing HorizonX Invests in Advanced Materials Producer Gamma Alloys
For 10 years running, the Family Office Club is the premier community for more than 1,500 registered family offices who manage USD1 trillion+ in assets
strona główna  |  oferty pracy  |  executive search  |  ochrona prywatności  |  warunki używania  |  kontakt     RSS feed subskrypcja RSS
Copyright ASTROMAN © 1995-2017. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: TAU CETI.